×
A 24-Week, Multicenter, Open-Label, Randomized Study to Compare Changes in Glucose Metabolism in Patients With Schizophrenia Receiving Treatment With Olanzapine, Quetiapine, or Risperidone PDF
$ 40.00
A 24-Week, Multicenter, Open-Label, Randomized Study to Compare Changes in Glucose Metabolism in Patients With Schizophrenia Receiving Treatment With Olanzapine, Quetiapine, or Risperidone PDF quantity
$ 40.00
×
Evaluation of Changes in Citalopram Prescribing Patterns Following a US Food and Drug Administration Alert: A Retrospective Cohort Study PDF
$ 40.00
Evaluation of Changes in Citalopram Prescribing Patterns Following a US Food and Drug Administration Alert: A Retrospective Cohort Study PDF quantity
$ 40.00
×
Commentary on “Catatonia and Competency to Stand Trial With Unique Response to Haloperidol” PDF
$ 40.00
Commentary on “Catatonia and Competency to Stand Trial With Unique Response to Haloperidol” PDF quantity
$ 40.00
×
Aripiprazole Augmentation in Clozapine-Treated Patients With Refractory Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial PDF
$ 40.00
Aripiprazole Augmentation in Clozapine-Treated Patients With Refractory Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
